Adcock Ingram Holdings Ltd (ISIN ZAE000005229) is a South African pharmaceuticals and healthcare group with a long history in the country. The company manufactures, markets and distributes prescription medicines, over-the-counter remedies, consumer health products and hospital supplies for both public and private sector customers
Pharmaceutical footprint in South Africa
Adcock Ingram operates as a key player in South Africa’s pharmaceutical supply chain, running manufacturing facilities that produce a wide range of generic and branded medicines. The company participates in tender processes for public-sector contracts and serves private pharmacies, clinics and hospitals through established distribution channels
Its portfolio typically spans acute and chronic therapies, including anti-infectives, pain management, cardiovascular treatments and other widely used medications. Alongside prescription drugs, Adcock Ingram is active in the consumer health segment, offering branded over-the-counter products aimed at everyday ailments such as colds, flu, pain and digestive issues
Business model and strategic focus
Adcock Ingram’s business model combines manufacturing, marketing and logistics capabilities to support a broad product mix. The company invests in quality control and regulatory compliance to meet local health authority requirements, while focusing on efficiency in production and distribution to manage costs in a competitive environment
Strategically, the group emphasizes maintaining and expanding its presence in core therapeutic areas and consumer health categories where its brands are well known. It also seeks to balance exposure between public and private sector demand, which can be influenced by economic conditions, health policy decisions and demographic trends in South Africa
Go deeper
Explore more on Adcock Ingram
Learn more about Adcock Ingram Holdings Ltd as a South African pharmaceuticals and healthcare company, including its investor information and corporate profile
More on Adcock Ingram Holdings LtdInvestor Relations
Representative consumer health portfolio
Adcock Ingram’s consumer health operations center on recognizable over-the-counter brands designed for home use. These products are sold through pharmacies, supermarkets and other retail outlets, offering a mix of analgesics, cold and flu remedies, vitamins, supplements and personal care items. The consumer business complements its prescription and hospital-focused lines by providing a direct link to end buyers and supporting brand equity
Stock context and local listing
Adcock Ingram shares are listed on the Johannesburg Stock Exchange, giving investors exposure to South Africa’s healthcare and pharmaceuticals sectorns for demand in medicines and health products, the stability of public and private healthcare spending, and the company’s ability to manage costs and maintain reliable supply
Adcock Ingram quick facts
- Company: Adcock Ingram Holdings Ltd
- ISIN: ZAE000005229
- Ticker: Not specified
- Exchange: Johannesburg Stock Exchange
- Price (as of latest available data): Not specified
- Market cap: Not specified
- Sector / Industry: Pharmaceuticals and healthcare
- Index membership: Not specified
- Next earnings date: Not yet officially scheduled
Find more on Adcock Ingram stock
This article was generated automatically and technically reviewed before publication. Market prices, analyst data and company information are provided without warranty and may change at short notice. This content is for informational purposes only and is not investment, financial, legal or tax advice. It is not a recommendation to buy or sell any security. Investing in securities involves risk, including the possible loss of principal
en | ZAE000005229 | ADCOCK INGRAM | boerse | 69697372 | bgmi
